FutureLink 2023 Conference Insights on DSCSA Compliance

This document is a report on the FutureLink 2023 conference organized by TraceLink Inc., focusing on the Drug Supply Chain Security Act (DSCSA) compliance and supply chain digitalization. The conference featured a range of activities, including keynotes, educational presentations, master classes, and roundtable discussions aimed at enhancing collaboration among life sciences manufacturers, healthcare providers, and retail pharmacy chains. Attendees engaged in discussions about meeting DSCSA deadlines, addressing drug shortages, and improving product orchestration across the supply chain. Notable sessions included a panel discussion featuring industry leaders sharing insights on DSCSA solutions, a deep-dive track on DSCSA requirements, and a fireside chat addressing emerging opportunities in supply chain intelligence. The report highlights TraceLink's ongoing efforts to support compliance and digital transformation in the pharmaceutical supply chain, detailing their extensive network and the significant volume of transactions processed to meet regulatory requirements. FutureLink 2024 is already in planning, indicating continued focus on these critical industry challenges.